Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-08-18

Clinical Trial Update: Preemptive Acetaminophen for Postoperative Pain Control Following Minimally Invasive Hysterectomy [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial evaluating preemptive acetaminophen for postoperative pain control after minimally invasive hysterectomy was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Acetaminophen (Acetaminophen)

Snippet

Sponsor: Montefiore Medical Center | Conditions: Post Operative Pain | Phase 2, Phase 3 | Status: WITHDRAWN